The loss of SMAD4 protein expression in tissue specimens from patients with eCCA who underwent surgical resection has been shown to be associated with poor prognosis [112], supporting the clinical significance of SMAD4 mutations and deletions in CCA. Here, SMAD4 is linked to cholangiocarcinoma.